Dr. Yuval Yarkoni earned his Ph.D. in Immunology in 2005 after researching an autoimmune disease called Lupus. His study focused on autoantibodies that are forming due to loss of tolerance in a murine model of Lupus. Along the Ph.D years he also worked as a lecturer, teaching medical students. Later he completed his postdoc studies in Immunology at the University of Colorado-Denver, generating antibodies as a research tool to study signal transduction pathways in B cells and their role in immune tolerance mechanisms.
Dr Yarkoni started his career in the biotech / Pharma industry in 2015, working as a scientist and generating antibodies from a human phage display library, work that led to 4 different antibodies entering the drug development process. One of these antibodies was used as the monoclonal antibody (mAb) for an Antibody Drug Conjugate (ADC), starting an on-going interest in this type of therapeutics.
While he started working as a scientist, he also worked as a Project Manager, initially as a PM in early stage drug discovery, then a PM in a manufacturing role, later as a PM in clinical distribution role and lastly as a PM in a CMC role. Dr Yarkoni earned his Project Management Professional (PMP) certification in 2018.
Outside of work, Dr. Yarkoni enjoys hiking, cooking, cycling and Yoga, which provides a well-rounded balance to his professional life.
